| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $39.1M | +1361.8% |
| Cost of Revenue | $8.7M | +278.1% |
| Gross Profit | $30.4M | +7985.1% |
| R&D Expense | $16.5M | +111.0% |
| SG&A Expense | $35.1M | +261.0% |
| Operating Income | -$32.5M | -53.6% |
| Interest Expense | $20.0M | +1470.9% |
| Pre-tax Income | -$79.0M | -53.6% |
| Income Tax | $5K | — |
| Net Income | -$79.0M | -53.7% |
| EPS (Basic) | -$0.52 | +96.8% |
| EPS (Diluted) | -$0.52 | +96.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.0M | -39.8% |
| Accounts Receivable | $888K | +154.4% |
| Inventory | $636K | -60.7% |
| Current Assets | $142.9M | +2118.9% |
| Total Assets | $274.7M | +173.0% |
| Current Liabilities | $26.9M | +553.6% |
| Total Liabilities | $36.7M | +146.5% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$23.6M | -34.7% |
| Capital Expenditures | $380K | +985.7% |
| Investing Cash Flow | -$7.9M | -406.1% |
| Financing Cash Flow | $30.2M | +37.1% |
| Free Cash Flow | -$24.0M | -36.6% |
| $238.0M |
| +177.6% |